Clinical Trial: Topical 0.4% Ketorolac and Vitreoretinal Surgery

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study

Brief Summary: To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.